Dr. Sami Ulus Maternity and Children Training and Research Hospital, Department of Pediatrics, University of Health Sciences, Ankara, Turkey.
Dr. Sami Ulus Maternity and Children Training and Research Hospital, Pediatric Allergy and Immunology Department, University of Health Sciences, Ankara, Turkey.
J Allergy Clin Immunol Pract. 2022 Jun;10(6):1608-1613. doi: 10.1016/j.jaip.2022.02.013. Epub 2022 Feb 22.
Food protein-induced allergic proctocolitis (FPIAP) is a food allergy characterized by bloody stools in well-appearing breast-fed infants.
To determine the clinical course of FPIAP and the factors affecting the development of tolerance.
Over a 10-year period, patients with a diagnosis of FPIAP who were followed at the outpatient Allergy-Immunology clinic in a tertiary care children's hospital in Turkey were retrospectively analyzed.
The frequency of FPIAP was 0.18% among 64,549 patients. The median age of symptom onset was 2 months (interquartile range, 1.0-3.5 months), and the median age of tolerance development was 12 months (interquartile range, 8.0-17.21 months). The occurrence of symptoms in the neonatal period was associated with a history of premature birth (odds ratio, 3.75; 95% CI, 1.33-10.59; P = .031) and neonatal intensive care unit hospitalization (odds ratio, 4.72; 95% CI, 1.78-12.53; P = .002). Use of a cow's milk-based formula was associated with a higher risk of the onset of symptoms after 1 month (odds ratio, 2.69; 95% CI, 1.19-6.07; P = .016). The use of an amino acid-based formula and the presence of diarrhea at admission were associated with later development of tolerance (P = .023 and P < .001, respectively). An IgE-mediated reaction was observed during oral food challenge testing in 6% of the patients.
The manifestations of FPIAP appeared earlier in premature infants and later in infants using formula. The use of amino acid-based formula and having had diarrhea were associated with delayed tolerance.
食物蛋白诱导的过敏直肠结肠炎(FPIAP)是一种以外观良好的母乳喂养婴儿出现血性粪便为特征的食物过敏。
确定 FPIAP 的临床过程以及影响耐受发展的因素。
在土耳其一家三级儿童保健医院的门诊过敏免疫诊所,对 10 年来被诊断为 FPIAP 的患者进行回顾性分析。
FPIAP 在 64549 例患者中的发病率为 0.18%。症状发作的中位年龄为 2 个月(四分位间距,1.0-3.5 个月),耐受发展的中位年龄为 12 个月(四分位间距,8.0-17.21 个月)。新生儿期出现症状与早产史(比值比,3.75;95%置信区间,1.33-10.59;P =.031)和新生儿重症监护病房住院史(比值比,4.72;95%置信区间,1.78-12.53;P =.002)相关。使用牛奶基配方与 1 个月后症状发作风险增加相关(比值比,2.69;95%置信区间,1.19-6.07;P =.016)。使用氨基酸基配方和入院时存在腹泻与后期耐受发展相关(P =.023 和 P <.001)。在口服食物激发试验中,6%的患者出现 IgE 介导的反应。
FPIAP 的表现早产儿中更早出现,而在使用配方奶的婴儿中出现更晚。使用氨基酸基配方和腹泻与延迟耐受相关。